Nizatidine Capsule
Product Images NDC 0591-3137

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nizatidine (NDC 0591-3137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of Nizatidine, showing the molecular formula C12H21N5O2S2 and molecular weight 331.46. The structure includes a thiazole ring and various functional groups characteristic of the compound.*

FDA Label Image

Image 2

Nizatidine Capsules, USP 150 mg packaging label from Actavis Pharma, Inc. The label shows a white capsule with imprint '3137 WPI', indicating 60 capsules per bottle. It includes storage instructions, manufacturer details (Watson Pharma Limited, India), and distribution info (Actavis Pharma, Parsippany, NJ). The label also features dosage information and a barcode.*

FDA Label Image

Image 3

Nizatidine Capsules USP 300 mg label from Actavis Pharma, Inc. The label shows an orange capsule with imprint '3138 WP1', indicates a package size of 30 capsules, and includes dosage and storage information. The labeler is Actavis Pharma, Inc., with manufacturing details from Watson Pharma Private Limited, India. The label also contains a barcode and specifies the product as prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.